DBT
TEVA icon

Dubuque Bank & Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Dubuque Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-90
Closed -$3K – 686
2016
Q4 		$3K Hold
90
– – ﹤0.01% 512
2016
Q3 		$4K Hold
90
– – ﹤0.01% 475
2016
Q2 		$5K Hold
90
– – ﹤0.01% 490
2016
Q1 		$5K Sell
90
-331
-79% -$19.4K ﹤0.01% 536
2015
Q4 		$28K Buy
421
+331
+368% +$20.5K 0.01% 355
2015
Q3 		$5K Hold
90
– – ﹤0.01% 505
2015
Q2 		$5K Hold
90
– – ﹤0.01% 541
2015
Q1 		$6K Hold
90
– – ﹤0.01% 500
2014
Q4 		$5K Hold
90
– – ﹤0.01% 495
2014
Q3 		$5K Buy
+90
New +$4.77K ﹤0.01% 498
2013
Q4 		– Sell
-239
Closed -$9K – 439
2013
Q3 		$9K Sell
239
-102
-30% -$3.98K ﹤0.01% 343
2013
Q2 		$13K Buy
+341
New +$13.3K ﹤0.01% 270

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dubuque Bank & Trust's TEVA Position: Q1 2017 in Review

Dubuque Bank & Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 90 shares — an estimated $3K sold.

Dubuque Bank & Trust first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $28K in Q4 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Dubuque Bank & Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
  • Dubuque Bank & Trust sold 90 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $3K.
  • Dubuque Bank & Trust first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 12 quarters.
  • Dubuque Bank & Trust's Teva Pharmaceutical Industries Limited position peaked at $28K in Q4 2015.
  • 688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Dubuque Bank & Trust's 13F filing for Q1 2017, filed 25 Apr 2017.